Adverse effects of crystalloid and colloid fluids

Area of Science:

• Critical Care Medicine
• Fluid Therapy
• Pharmacology

Background:

• Adverse effects of infusion fluids are dose-dependent and often overlooked in guidelines.
• Crystalloid fluid administration can lead to interstitial edema, prolonged gastrointestinal recovery, and impaired wound healing.
• Colloid fluids carry risks of anaphylaxis and potential kidney injury, with both fluid types impacting coagulation.

Purpose of the Study:

• To review the dose-dependent adverse effects of crystalloid and colloid infusion fluids.
• To provide recommendations for balancing fluid administration to mitigate adverse events.
• To suggest appropriate use of colloid fluids in relation to crystalloid volumes.

Main Methods:

• Literature review of studies on crystalloid and colloid fluid therapy.
• Analysis of dose-dependent adverse effects, including organ dysfunction and coagulopathy.
• Evaluation of pathophysiological differences in fluid-induced edema.

Main Results:

• Excessive crystalloid infusion (>2L) prolongs GI recovery; >6-7L risks poor wound healing, pulmonary edema, and pneumonia.
• Large fluid volumes can cause organ dysfunction by disrupting the interstitial matrix.
• Coagulopathy occurs at 40% hemodilution, worsened by hypothermia; anaphylaxis risk with colloids is 1:500.

Conclusions:

• Colloid fluid administration is indicated when crystalloid volume exceeds 3-4 liters and plasma volume support is still required, provided blood products are not yet indicated.
• Careful consideration of fluid type and volume is crucial to minimize dose-dependent adverse effects.
• Understanding the distinct pathophysiologies of crystalloid and colloid-induced edema is key for safe fluid management.